July 3, 2023

Sue Peschin – FDA, CMS, and Alzheimer’s Drugs: What Do American Voters Want?

About This Episode

Should Alzheimer’s drugs be treated like all other drugs when it comes to Medicare coverage? The Alliance for Aging Research CEO Sue Peschin and BrainStorm host Meryl Comer dive into polling data that reveals most American voters, regardless of party, disagree with CMS’s policy that will limit access. Their conversation sheds light on how the coverage decision, if it stands, will create not only greater disparities, but also have wide-ranging implications on coverage for other disease-modifying therapies. 

This episode is sponsored by Eisai.

Support the show

BrainStorm Feed

120

The Financial Toll of Caregiving with Ken and Maddy Dychtwald

It is time to treat caregiving as a societal issue rather than a private family matter. More than 32 million Americans are financial caregivers for

LISTEN NOW
119

The Fine Print on Your Prescriptions: What Families Need to Know About Medicare Part D

You picked a Medicare drug plan in December. Then in January, the pharmacist tells you your medication isn’t covered, or that it needs approval first

LISTEN NOW
118

Risky Business: The Costliest Assumptions for Medicare Families

In part one of BrainStorm’s look at Medicare open enrollment, host Meryl Comer talks with Alison Schneider, Director of Market Access Policy and Strategy at

LISTEN NOW